Mast cell activation and tumor necrosis factor-alpha production pathway

The mast cell activation and tumor necrosis factor-alpha (TNF-alpha) production pathway is a fundamental signaling axis in the immune system, primarily responsible for initiating rapid inflammatory responses to allergens and pathogens. Mast cells, located at mucosal and cutaneous interfaces, are activated when multivalent antigens cross-link IgE antibodies bound to the high-affinity FcεRI receptor. This event triggers a sophisticated intracellular signaling cascade involving tyrosine kinases such as SYK and BTK, leading to the immediate exocytosis of preformed mediators—including TNF-alpha—and the transcriptional upregulation of new cytokine synthesis [1][2]. TNF-alpha serves as a critical pleiotropic cytokine that amplifies the inflammatory milieu by inducing adhesion molecule expression on endothelial cells and recruiting neutrophils and T-cells. Dysregulation of this pathway is implicated in a wide range of pathologies, from acute anaphylaxis and allergic asthma to chronic inflammatory diseases like rheumatoid arthritis and mastocytosis [3]. Therapeutic targeting of this pathway involves diverse strategies, including IgE sequestration (Omalizumab), mast cell stabilization (Cromolyn), kinase inhibition (Fostamatinib), and direct TNF-alpha neutralization (Infliximab), reflecting its central role in immune-mediated morbidity. Citations: [1] Wernersson S, Pejler G. Nature Reviews Immunology. 2014;14(7):478-494. [2] Galli SJ, et al. Nature. 2005;433(7025):477-485. [3] Mukhopadhyay S, et al. Int J Mol Sci. 2023;24(11):9456.

Other names

Mast cell activation / TNF-alpha production pathwayMast cell degranulation pathwayFcεRI signaling pathwayIgE-mediated mast cell activationMast cell TNF-alpha release pathway

Drugs targeting this pathway act by sequestering IgE to prevent receptor cross-linking, stabilizing the mast cell membrane to inhibit mediator release, blocking intracellular signaling kinases such as SYK or BTK to prevent cytokine transcription, or directly neutralizing the secreted TNF-alpha protein [1][2][3].